Cargando…

Pelargonium sidoides extract EPs 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children

BACKGROUND: In numerous randomized controlled trials (RCTs) and systematic reviews such as those published by the Cochrane Collaboration, Pelargonium sidoides extract EPs(®) 7630 was shown to be effective in acute respiratory tract infections (aRTI) in all investigated age-groups. This narrative rev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Careddu, Domenico, Pettenazzo, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849386/ https://www.ncbi.nlm.nih.gov/pubmed/29563828 http://dx.doi.org/10.2147/IJGM.S154198

Ejemplares similares

Antimicrobial, Antiviral and Immunomodulatory Activity Studies of Pelargonium sidoides (EPs(®) 7630) in the Context of Health Promotion
por: Kolodziej, Herbert
Publicado: (2011)

The Pelargonium sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes
por: Witte, Katrin, et al.
Publicado: (2015)

Up-Regulated Vitamin D Receptor by Pelargonium sidoides Extract EPs(®) 7630 Contributes to Rhinovirus Defense in Bronchial Epithelial Cells
por: Roth, Michael, et al.
Publicado: (2021)

Safety of Pelargonium extract EPs 7630 in young children with acute bronchitis
por: Kamin, Wolfgang, et al.
Publicado: (2023)

Effects of Pelargonium sidoides extract EPs 7630 on acute cough and quality of life – a meta-analysis of randomized, placebo-controlled trials
por: Kardos, Peter, et al.
Publicado: (2022)

Investigation of the influence of EPs(®) 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses
por: Michaelis, Martin, et al.
Publicado: (2011)

Pelargonium sidoides radix extract EPs 7630 reduces rhinovirus infection through modulation of viral binding proteins on human bronchial epithelial cells
por: Roth, Michael, et al.
Publicado: (2019)

Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells
por: Papies, Jan, et al.
Publicado: (2021)

Evaluation of pharmacodynamic activities of EPs(®) 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis
por: Bao, Yanyan, et al.
Publicado: (2015)

Corrigendum: Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs(®) 7630 in SARS-CoV-2-Infected Human Lung Cells
por: Papies, Jan, et al.
Publicado: (2021)

HATRIC: a study of Pelargonium sidoides root extract EPs®7630 (Kaloba®) for the treatment of acute cough due to lower respiratory tract infection in adults—study protocol for a double blind, placebo-controlled randomised feasibility trial
por: Whitehead, Amy, et al.
Publicado: (2019)

Medicinal properties and conservation of Pelargonium sidoides DC.
por: Moyo, Mack, et al.
Publicado: (2014)

In vitro and in vivo effects of Pelargonium sidoides DC. root extract EPs(®) 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/AY.117 and Omicron BA.2
por: Emanuel, Jackson, et al.
Publicado: (2023)

Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections – A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial
por: Keck, Tilman, et al.
Publicado: (2021)

Investigation of Antibacterial and Antiinflammatory Activities of Proanthocyanidins from Pelargonium sidoides DC Root Extract
por: Jekabsone, Aiste, et al.
Publicado: (2019)

Antioxidant and antimicrobial properties of Pelargonium sidoides DC and lactoferrin combination
por: Terlizzi, Michela, et al.
Publicado: (2020)

The Root Extract of the Medicinal Plant Pelargonium sidoides Is a Potent HIV-1 Attachment Inhibitor
por: Helfer, Markus, et al.
Publicado: (2014)

Efficacy of Proanthocyanidins from Pelargonium sidoides Root Extract in Reducing P. gingivalis Viability While Preserving Oral Commensal S. salivarius
por: Savickiene, Nijole, et al.
Publicado: (2018)

Novel kinase platform for the validation of the anti-tubercular activities of Pelargonium sidoides (Geraniaceae)
por: Lukman, V., et al.
Publicado: (2020)

Yield and Metabolite Production of Pelargonium sidoides DC. in Response to Irrigation and Nitrogen Management
por: Mofokeng, Motiki M., et al.
Publicado: (2020)

Effects of Pelargonium sidoides extract on chemokine levels in nasal secretions of patients with non-purulent acute rhinosinusitis
por: Perić, Aleksandar, et al.
Publicado: (2020)

Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults: a feasibility double-blind, placebo-controlled randomised trial
por: Willcox, Merlin, et al.
Publicado: (2021)

Faster recovery and reduced paracetamol use – a meta-analysis of EPs 7630 in children with acute respiratory tract infections
por: Seifert, Georg, et al.
Publicado: (2019)

Effects of Pelargonium sidoides extract vs roxithromycin on chemokine levels in nasal secretions of patients with uncomplicated acute rhinosinusitis
por: Perić, Aleksandar, et al.
Publicado: (2020)

Interaction of Pelargonium sidoides Compounds with Lactoferrin and SARS-CoV-2: Insights from Molecular Simulations
por: Iacovelli, Federico, et al.
Publicado: (2022)

Bioactive Compound Produced by Endophytic Fungi Isolated From Pelargonium sidoides Against Selected Bacteria of Clinical Importance
por: Manganyi, Madira Coutlyne, et al.
Publicado: (2019)

Efficacy and tolerability of EPs 7630 in patients (aged 6–18 years old) with acute bronchitis
por: Kamin, W, et al.
Publicado: (2010)

Pelargonium sidoides Root Extract: Simultaneous HPLC Separation, Determination, and Validation of Selected Biomolecules and Evaluation of SARS-CoV-2 Inhibitory Activity
por: Alossaimi, Manal A., et al.
Publicado: (2022)

Effects of EPs 7630 on the duration of inability to work in acute bronchitis – a meta-analysis
por: Matthys, Heinrich, et al.
Publicado: (2023)

Effects of Pelargonium sidoides and Coptis Rhizoma 2 : 1 Mixed Formula (PS + CR) on Ovalbumin-Induced Asthma in Mice
por: Min, Byung Gu, et al.
Publicado: (2020)

Combination of Pelargonium sidoides and Coptis chinensis root inhibits nuclear factor kappa B-mediated inflammatory response in vitro and in vivo
por: Park, Sang Mi, et al.
Publicado: (2018)

Draft Genome Sequence of Bacillus sp. strain YC2, an Isolate from the South African Medicinal Plant Pelargonium sidoides
por: Mqulwa, Aza Z., et al.
Publicado: (2022)

Treatment of signs and symptoms of the common cold using EPs 7630 - results of a meta-analysis
por: Schapowal, Andreas, et al.
Publicado: (2019)

The herbal extract EPs® 7630 increases the antimicrobial airway defense through monocyte-dependent induction of IL-22 in T cells
por: Witte, Katrin, et al.
Publicado: (2020)

EPs(®) 7630 Stimulates Tissue Repair Mechanisms and Modifies Tight Junction Protein Expression in Human Airway Epithelial Cells
por: Fang, Lei, et al.
Publicado: (2023)

The pollen morphology of Pelargonium endlicherianum and Pelargonium quercetorum (Geraniaceae) in Turkey
por: Başer, Birol, et al.
Publicado: (2016)

Functional Analysis of Four Terpene Synthases in Rose-Scented Pelargonium Cultivars (Pelargonium × hybridum) and Evolution of Scent in the Pelargonium Genus
por: Blerot, Bernard, et al.
Publicado: (2018)

Evaluation of food effects on the pharmacokinetics of Pelargonium sidoides and Coptis with each bioactive compound berberine and epicatechin after a single oral dose of an expectorant and antitussive agent UI026 in healthy subjects
por: Park, Yewon, et al.
Publicado: (2022)

Pelargoniums of Southern Africa /
por: Van der Walt, J. J. A. (Johannes Jacobus Adriaan), 1925-
Publicado: (1977)

Chemical composition and biological investigation of Pelargonium endlicherianum root extracts
por: Şeker Karatoprak, Gökçe, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2dfu4lg2hahf966fdf13rjtpmo